Press Releases

Echo is revolutionizing the quantified self.

We see a tremendous opportunity to deliver technology that will empower millions of people around the world to take better care of themselves and create a healthier world.

Archives: Search / 2016 / 2015 / 2014

2016 Archives

Dec 21, 2016
Echo Therapeutics Announces Dismissal of Federal Court Action
Dec 12, 2016
Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order
Aug 12, 2016
Echo Therapeutics, Inc. Announces Second Quarter 2016 Financial Results
Jul 8, 2016
Echo Therapeutics Common Stock to Transition from NASDAQ to OTCQB
Jun 29, 2016
Echo Therapeutics Begins Testing of NextGen CGM System Components
Company Selects Clinical Research Organization for Clinical and Regulatory Pathway
Jun 22, 2016
Echo Therapeutics Announces New Patent for its Non-Invasive Sensing Technology
Jun 13, 2016
Echo Therapeutics Announces Institutional Review Board (IRB) Approval of New Protocol
Jun 2, 2016
Echo Therapeutics in Final Stage of Clinical Research Organization (CRO) Selection
May 20, 2016
Echo Therapeutics, Inc. Announces First Quarter 2016 Financial Results
May 17, 2016
Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA
May 4, 2016
Echo Therapeutics Announces Final Closing of Private Placement of $5.1 Million of Convertible Notes and Warrants
May 3, 2016
Echo Therapeutics Announces Significant Progress in Key Development Milestones
Apr 28, 2016
Echo Therapeutics Announces Conference Call to Provide an Update on Corporate Milestones
Conference Call to be held on Wednesday, May 4, 2016 at 4:30 p.m. ET
Apr 14, 2016
Echo Therapeutics Announces Voting Results of Special Meeting of Stockholders
Shareholders Approve Issuance of Common Stock Shares in Connection with Recent Financing
Mar 30, 2016
Echo Therapeutics, Inc. Announces 2015 Financial Results
Feb 22, 2016
Echo Therapeutics Announces New Patents for Non-Invasive Sensing Technology
Feb 8, 2016
Echo Therapeutics Announces Conference Call and Webcast to Provide a Corporate Update
Feb 1, 2016
Echo Therapeutics Announces Entry Into Definitive Agreements for the Sale of up to $5.1 Million of Convertible Notes and Warrants